T-3262 IN OBSTETRICS AND GYNECOLOGY
スポンサーリンク
概要
- 論文の詳細を見る
T-3262, a new synthetic antibacterial agent was evaluated clinically in the field of obstetrics and gynecology. The following results were obtained.<BR>Seven patients with adnexitis, 1 with pelvic peritonitis, 1 with parametritis, 2 with Bartholin's abscess and 1 with cystitis were treated with T-3262 at a daily dose of 450 mg for 5-14 days.<BR>Clinical effect was excellent in 1, good in 10, poor in 1, and the efficacy rate was 91.7%. No side effects due to T-3262 were noted.
- 公益社団法人 日本化学療法学会の論文
公益社団法人 日本化学療法学会 | 論文
- DISPOSITION OF 7432-8 IN RATS (I)
- CLINICAL STUDIES ON T-1220 IN SURGICAL CASES
- CLINICAL STUDIES OF PIVALOYLOXYMETHYL D-α-AMINOBENZYL-PENICILLINATE HYDROCHLORIDE IN SURGICAL INFECTIONS
- STUDIES ON AC-1370
- Primary treatment with a combination of cyclophosphamide, vincristine, and dacarbazine for recurrent malignant pheochromocytoma: A case report.